Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients
Información
- DOI:
- https://doi.org/10.1002/14651858.CD006300.pub3Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 12 diciembre 2012see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Cáncer infantil
- Copyright:
-
- Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Renée L Mulder identified studies meeting the inclusion criteria. She searched for unpublished and ongoing studies. She contributed to the interpretation of the results. She wrote and revised the review.
Marios Paulides designed the study and wrote the protocol. He identified studies meeting the inclusion criteria. He contributed to the interpretation of the results. He critically reviewed the review.
Wolfgang Stöhr critically reviewed the protocol. He contributed to the interpretation of the results. He critically reviewed the review.
Thorsten Langer critically reviewed the protocol. He contributed to the interpretation of the results. He critically reviewed the review.
Leontien CM Kremer designed the study and critically reviewed the protocol. She contributed to the interpretation of the results. She critically reviewed the review.
Elvira C van Dalen designed the study and wrote the protocol. She developed the search strategy. She identified the studies meeting the inclusion criteria. She searched for unpublished and ongoing studies. She interpreted the results. She wrote and revised the review.
All authors approved the final version.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Foundation of Pediatric Cancer Research (SKK) Amsterdam, Netherlands.
-
Stichting Kinderen Kankervrij (KIKA), Netherlands.
Declarations of interest
None known.
Acknowledgements
Leontien Kremer, the Co‐ordinating Editor of the Childhood Cancer Group, is a co‐author of this review and therefore she could not act as the Co‐ordinating Editor for this review. Prof. Dr. Huib Caron (Department of Paediatric Oncology of the Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands) was willing to take on this task, for which we would like to thank him. Also, we would like to thank Edith Leclercq, the Trials Search Co‐ordinator of the Childhood Cancer Group, for running the search strategy in the different databases and providing us with the titles and abstracts of the searches and Wolfgang Stöhr for his help in preparing the protocol for this review. The editorial base of the Cochrane Childhood Cancer Group is funded by Kinderen Kankervrij (KIKA).
Version history
| Published | Title | Stage | Authors | Version |
| 2015 Sep 30 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Review | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
| 2012 Dec 12 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Review | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
| 2010 Feb 17 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Review | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
| 2006 Oct 18 | Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | Protocol | Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen | |
